Trial Profile
Hemoglobin glutamer-250 (HBOC-201) in patients undergoing non-cardiac surgery.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Hemoglobin glutamer (Primary)
- Indications Haemorrhagic shock
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2015 New trial record